ReviewTherapeutic advances in endocrinology and metabolism2021
Should metformin remain the first-line therapy for treatment of type 2 diabetes?
Chelsea Baker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
84 papers cite itlatest 60 shown
this paperpooled ittrialcites it